X0206 3 2018-11-13 0 0001253176 VAPOTHERM INC VAPO 0001755898 Dungan George C/O VAPOTHERM, INC. 100 DOMAIN DRIVE EXETER NH 03833 0 1 0 0 See Remarks Common Stock 9105 D Option to purchase Common Stock 1.54 2022-08-13 Common Stock 474 D Option to purchase Common Stock 1.54 2023-07-01 Common Stock 506 D Option to purchase Common Stock 1.54 2024-04-16 Common Stock 2074 D Option to purchase Common Stock 1.54 2024-07-01 Common Stock 2945 D Option to purchase Common Stock 1.54 2025-04-16 Common Stock 7880 D Option to purchase Common Stock 1.54 2026-01-20 Common Stock 4058 D Option to purchase Common Stock 1.68 2026-01-20 Common Stock 4711 D Option to purchase Common Stock 1.68 2027-01-18 Common Stock 5044 D Option to purchase Common Stock 1.68 2027-10-18 Common Stock 4836 D The option vested and became exercisable as to 25% of the underlying shares on August 13, 2013 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter. The option vested and became exercisable as to 25% of the underlying shares on July 1, 2014 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter. The option vested and became exercisable as to 25% of the underlying shares on April 16, 2015 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter. The option vested and became exercisable as to 25% of the underlying shares on July 1, 2015 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter. The option vests and becomes exercisable as to 25% of the underlying shares on April 16, 2016 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. The option vests and becomes exercisable as to 25% of the underlying shares on January 20, 2017 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. The option vests and becomes exercisable as to 25% of the underlying shares on January 20, 2017 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. The option vests and becomes exercisable as to 25% of the underlying shares on January 18, 2018 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. The option vests and becomes exercisable as to 25% of the underlying shares on October 18, 2018 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Vice President, Science & Innovation Exhibit List Exhibit 24 - Power of Attorney /s/ John Landry, as Attorney-In-Fact 2018-11-13